4
Changes in Ownership
BioAge Labs, Inc. Filed Acc 0001210905-26-000002
Chief Medical Officer sold 7,433 shares at $12.85 ($95,490)
- Chief Medical Officer acquired 7,433 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
RUBIN PAUL D · Chief Medical Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-01-02 | Exercise or conversion : show line 1 in the form 10b5-1 | +5,433 | $4.11 | $22,330 | 5,433 | D |
| 2026-01-02 | Exercise or conversion : show line 2 in the form 10b5-1 | +2,000 | $6.57 | $13,140 | 7,433 | D |
| 2026-01-02 | Sale : show line 3 in the form 10b5-1 | −7,433 | $12.85 | $95,490 | 0 | D |
| Open-market sales · 7,433 sh · avg $12.85 · $95,490 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-01-02 | Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (Right to Buy) | −5,433 | 16,303 | D |
| 2026-01-02 | Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) | −2,000 | 7,383 | D |
Loading xslF345X05/form4-01062026_090157.xml…